This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moe, G. R.
Right arrow Articles by Granoff, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moe, G. R.
Right arrow Articles by Granoff, D. M.

 Previous Article  |  Next Article 

Infection and Immunity, June 2001, p. 3762-3771, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.3762-3771.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Functional Activity of Anti-Neisserial Surface Protein A Monoclonal Antibodies against Strains of Neisseria meningitidis Serogroup B

G. R. Moe, P. Zuno-Mitchell, S. S. Lee, A. H. Lucas, and D. M. Granoff*

Children's Hospital Oakland Research Institute, Oakland, California

Received 7 February 2001/Returned for modification 5 March 2001/Accepted 22 March 2001

Neisserial surface protein A (NspA) is currently being investigated with humans as a candidate vaccine for the prevention of meningococcal disease. Although NspA is highly conserved, the ability of anti-NspA antibodies to bind to or elicit complement-mediated bactericidal activity against diverse Neisseria meningitidis serogroup B strains is controversial. To evaluate strain differences in NspA surface accessibility and susceptibility to bactericidal activity, we prepared murine immunoglobulin G2a anti-NspA monoclonal antibodies (MAbs) and evaluated their functional activity against 10 genetically diverse N. meningitidis serogroup B strains. By colony Western blot, all 10 strains expressed NspA as detected by one or more MAbs. By flow cytometry, two MAbs were found to bind to the bacterial surface of 6 of the 10 strains. In addition, two strains showed variable NspA surface accessibility for the MAbs despite being uniformly positive for NspA expression by colony Western blotting. Only 4 of the 10 strains were susceptible to anti-NspA complement-mediated bacteriolysis. Passively administered MAb protected infant rats from developing bacteremia after challenge with N. meningitidis serogroup B strain 8047 (surface binding positive, susceptible to anti-NspA bacteriolysis), was poorly protective against strain BZ232 (surface binding variable, resistant to bacteriolysis), and did not protect against strain M986 (surface binding negative, resistant to bacteriolysis). Finally, NspA does not appear to be critical for causing bacteremia, as an NspA knockout from strain 8047 was highly virulent in infant rats. Taken together, these findings suggest that an NspA-based vaccine will need to incorporate additional antigens to elicit broad protection against N. meningitidis serogroup B.

* Corresponding author. Mailing address: 5700 Martin Luther King Jr. Way, Oakland CA 94609. Phone: (510) 450-7640. Fax: (510) 450-7910. Email: dgranoff{at}chori.org.

Infection and Immunity, June 2001, p. 3762-3771, Vol. 69, No. 6
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.6.3762-3771.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Beernink, P. T., Granoff, D. M. (2008). Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines. Infect. Immun. 76: 2568-2575 [Abstract] [Full Text]  
  • Norheim, G., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Merid, Y., Hoiby, E. A., Caugant, D. A., Fritzsonn, E., Tangen, T., Melak, B., Berhanu, D., Harboe, M., Kolberg, J., Rosenqvist, E. (2008). Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci. CVI 15: 863-871 [Abstract] [Full Text]  
  • Moe, G. R., Dave, A., Granoff, D. M. (2005). Epitopes Recognized by a Nonautoreactive Murine Anti-N-Propionyl Meningococcal Group B Polysaccharide Monoclonal Antibody. Infect. Immun. 73: 2123-2128 [Abstract] [Full Text]  
  • Welsch, J. A., Granoff, D. (2004). Naturally Acquired Passive Protective Activity against Neisseria meningitidis Group C in the Absence of Serum Bactericidal Activity. Infect. Immun. 72: 5903-5909 [Abstract] [Full Text]  
  • Adu-Bobie, J., Lupetti, P., Brunelli, B., Granoff, D., Norais, N., Ferrari, G., Grandi, G., Rappuoli, R., Pizza, M. (2004). GNA33 of Neisseria meningitidis Is a Lipoprotein Required for Cell Separation, Membrane Architecture, and Virulence. Infect. Immun. 72: 1914-1919 [Abstract] [Full Text]  
  • Newcombe, J., Eales-Reynolds, L.-J., Wootton, L., Gorringe, A. R., Funnell, S. G. P., Taylor, S. C., McFadden, J. J. (2004). Infection with an Avirulent phoP Mutant of Neisseria meningitidis Confers Broad Cross-Reactive Immunity. Infect. Immun. 72: 338-344 [Abstract] [Full Text]  
  • Hou, V. C., Moe, G. R., Raad, Z., Wuorimaa, T., Granoff, D. M. (2003). Conformational Epitopes Recognized by Protective Anti-Neisserial Surface Protein A Antibodies. Infect. Immun. 71: 6844-6849 [Abstract] [Full Text]  
  • Vandeputte-Rutten, L., Bos, M. P., Tommassen, J., Gros, P. (2003). Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential. J. Biol. Chem. 278: 24825-24830 [Abstract] [Full Text]  
  • Harris, S. L., King, W. J., Ferris, W., Granoff, D. M. (2003). Age-Related Disparity in Functional Activities of Human Group C Serum Anticapsular Antibodies Elicited by Meningococcal Polysaccharide Vaccine. Infect. Immun. 71: 275-286 [Abstract] [Full Text]  
  • Moe, G. R., Zuno-Mitchell, P., Hammond, S. N., Granoff, D. M. (2002). Sequential Immunization with Vesicles Prepared from Heterologous Neisseria meningitidis Strains Elicits Broadly Protective Serum Antibodies to Group B Strains. Infect. Immun. 70: 6021-6031 [Abstract] [Full Text]  
  • Granoff, D. M., Moe, G. R., Giuliani, M. M., Adu-Bobie, J., Santini, L., Brunelli, B., Piccinetti, F., Zuno-Mitchell, P., Lee, S. S., Neri, P., Bracci, L., Lozzi, L., Rappuoli, R. (2001). A Novel Mimetic Antigen Eliciting Protective Antibody to Neisseria meningitidis. J. Immunol. 167: 6487-6496 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»